These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3478286)

  • 1. Rapid determination of five coagulation parameters in one sample with a centrifugal analyzer.
    Bas BM; Costongs GM; Janson PC
    Haemostasis; 1987; 17(5):260-7. PubMed ID: 3478286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of synthetic peptide substrate-based assays on a discrete analyzer.
    Aiach M; Léon M; Michaud A; Capron L
    Semin Thromb Hemost; 1983 Jul; 9(3):206-16. PubMed ID: 6351255
    [No Abstract]   [Full Text] [Related]  

  • 3. Automated instrumentation and the laboratory diagnosis of bleeding and thrombotic disorders.
    Walenga J; Fareed J; Bermes EW
    Semin Thromb Hemost; 1983 Jul; 9(3):172-93. PubMed ID: 6351253
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthetic peptide substrate assays in coagulation and fibrinolysis and their application on automates.
    Friberger P
    Semin Thromb Hemost; 1983 Oct; 9(4):281-300. PubMed ID: 6362011
    [No Abstract]   [Full Text] [Related]  

  • 5. Univariate tolerance regions for fibrinogen, antithrombin III, protein C, protein S, plasminogen and alpha 2-antiplasmin in children using the new Automated Coagulation Laboratory (ACL) method.
    Nowak-Göttl U; Funk M; Mosch G; Wegerich B; Kornhuber B; Breddin HK
    Klin Padiatr; 1994; 206(6):437-9. PubMed ID: 7529848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic efficacy of newer synthetic-substrates methods for assessing coagulation variables: a critical overview.
    Fareed J; Messmore HL; Walenga JM; Bermes EW
    Clin Chem; 1983 Feb; 29(2):225-36. PubMed ID: 6821923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; new synthetic chromogenic substrate assays for hemostatic parameters].
    Hiura H; Nishiyama T; Kimura M; Matoba K; Hayashi O; Sasaki M; Ishijima C; Irie Y; Yasuda N
    Rinsho Byori; 1989 Apr; Spec No 81():214-9. PubMed ID: 2754808
    [No Abstract]   [Full Text] [Related]  

  • 8. Automation in coagulation testing. Clinical applications.
    Messmore HL
    Semin Thromb Hemost; 1983 Oct; 9(4):341-5. PubMed ID: 6606852
    [No Abstract]   [Full Text] [Related]  

  • 9. Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance.
    Rodzynek JJ; Urbain D; Leautaud P; Wettendorff P; Delcourt A
    Gut; 1984 Oct; 25(10):1050-6. PubMed ID: 6479679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term and long-term intra-individual variations and critical differences of coagulation parameters.
    Costongs GM; Bas BM; Janson PC; Hermans J; Brombacher PJ; van Wersch JW
    J Clin Chem Clin Biochem; 1985 Jul; 23(7):405-10. PubMed ID: 4045388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. fibrinolysis=fibronolysis.
    Mitchell GA
    Semin Thromb Hemost; 1983 Oct; 9(4):268-80. PubMed ID: 6362010
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in antithrombin, antiplasmin, and plasminogen during and after cardiopulmonary bypass.
    Wolk LA; Wilson RF; Burdick M; Selik N; Brown J; Starricco A; Mammen EF
    Am Surg; 1985 Jun; 51(6):309-13. PubMed ID: 3873197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACL automated method for plasma inhibitors.
    Creter D
    Haematologica; 1990; 75(6):582. PubMed ID: 1711504
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthetic peptide substrates in hemostatic testing.
    Fareed J; Messmore HL; Walenga JM; Bermes EW
    Crit Rev Clin Lab Sci; 1983; 19(2):71-134. PubMed ID: 6373139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with chromogenic substrates in studies of clotting and fibrinolytic systems.
    Chmielewska J; Latallo ZS
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):111-4. PubMed ID: 6177591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin III, plasminogen, plasmin, and alpha-2-antiplasmin in donor blood and plasma components.
    McRoyan DK; McRoyan CJ; Sauter KL; Liu PI; Daniel SJ
    Ann Clin Lab Sci; 1985; 15(2):165-70. PubMed ID: 3158265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; measurement with new synthetic substrate method].
    Ujiie M; Kuroiwa K; Nagasawa T; Sato Y; Kitahara N
    Rinsho Byori; 1989 Apr; Spec No 81():208-13. PubMed ID: 2754807
    [No Abstract]   [Full Text] [Related]  

  • 18. [Automation of colorimetry using chromogenic substrates, with special reference to blood coagulation disorders in acute myelocytic leukemia].
    Hashizume K; Tanaki T; Horita H; Yoshitani H; Kumatani Y; Matsuda T; Ito K
    Rinsho Byori; 1985 Feb; Spec No 61():114-8. PubMed ID: 3858561
    [No Abstract]   [Full Text] [Related]  

  • 19. Automated determination of heparin with chromogenic substrates.
    van Putten J; van de Ruit M; Beunis M; Hemker HC
    Haemostasis; 1984; 14(2):184-94. PubMed ID: 6735276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoassay by particle counting for coagulation testing: application to the determination of antithrombin III, von Willebrand factor antigen (vWF:Ag) and plasminogen.
    Borque L; Cambiaso C; Lavenne E; Leautaud P; Mareschal JC; Collet-Cassart D
    J Clin Chem Clin Biochem; 1989 Mar; 27(3):175-9. PubMed ID: 2785154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.